HCV RNA/PCR (qualitative)

HCV RNA/PCR (qualitative)

Polymerase chain reaction (PCR) is a technique which is used to amplify the number of copies of RNA viral particles and, unlike hepatitis C antibody tests that look for the body response to the virus, a PCR (polymerase chain reaction) test looks for actual presence of the virus. There are 3 types of PCR tests:

HCV PCR viral detection test — looks for the virus, sometimes called 'qualitative test';
HCV PCR viral load test — looks for the virus and estimates how many HCV viruses per mL of blood, sometimes called 'quantitative test';
HCV PCR genotype test — looks for the virus, and determines the particular type/s of HCV.

PCR testing may be of benefit in cases of needle-stick and other sharps injury in healthcare settings or for exposure-prone sexual practices. When an individual is found to be positive for antibodies to HCV during blood donation or a health screening of at-risk populations, detection of HCV by RNA/PCR confirms chronic HCV infection. Despite improvements in the sensitivity of PCR technology, it’s important to assess HCV viral status on the basis of a minimum of 2 PCR tests — over a 6-month period — rather than on the basis of a single PCR test result. This is because it is possible for levels of hepatitis C virus in the bloodstream to fluctuate such that the level of virus may fall so low that the PCR test won’t pick it up. Thus, someone who tests PCR negative may still be infectious.

HCV RNA is detectable in serum within one to two weeks when accidental parenteral exposure results in infection.

Detection of HCV RNA without antibodies for HCV is strongly indicative of acute hepatitis C; this will be confirmed by subsequent seroconversion. Acute hepatitis C is unlikely if both markers are absent.

Even if people with HCV know their PCR status they should still avoid all blood-to-blood contact. In any situation involving potential blood-to-blood contact, it’s important for everyone to assume that they, and all others, are potentially infectious. If an HCV antibody positive person finds out they are PCR negative, they’d be making a big mistake in sharing any drug injecting equipment, snorting straws, razor blades or razors, tattooing equipment, toothbrushes or other equipment that could transfer blood.

When HCV RNA is undetectable on at least two occasions 6 months apart, it is difficult to distinguish patients who still harbor antibodies after spontaneously resolving HCV infection in the past from patients with false-positive reactivity.

Acute HCV infection is also unlikely if anti-HCV antibodies are present and HCV RNA absent; such cases generally correspond to patients whose liver disorders are due to another cause and who encountered and cleared HCV at some time in the past. These subjects should nonetheless be retested for HCV RNA a few weeks later, as HCV RNA may disappear transiently before chronic replication becomes detectable.

Finally, when both anti-HCV antibodies and HCV RNA are detected, it is difficult to distinguish acute hepatitis C from an acute exacerbation of chronic hepatitis C, and from acute hepatitis of another cause in a patient who also has chronic hepatitis C.

The diagnosis of acute infection should be based on HCV RNA testing with a sensitive technique. This can be done at any time starting one week after exposure. Antiviral treatment is not urgent in this setting, and can be initiated when symptoms or an increase in serum aminotransferase activity occurs.

STDWeB provides only health screening services. Tests are provided only for personal information and/or risk identification purposes. STDWeB does not diagnose or treat medical conditions. STDWeB screenings do not take the place of a physician care. Transactions with STDWeB are confidential and will not be shared with third parties. Tests with "positive" or "indeterminate" result may require confirmatory testing and may involve additional charges.